Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00179621
Status:
COMPLETED
Last Update Posted:
2011-04-14
First Post:
2005-09-10
Brief Title:
Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q31 Abnormality
Sponsor:
Celgene Corporation
Organization:
Celgene